Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Amiodarone Market Growth 2022-2028

  • LP 4848511
  • 108 Pages
  • February 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Amiodarone will have significant change from previous year. According to our (LP Information) latest study, the global Amiodarone market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Amiodarone market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Amiodarone market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Amiodarone market, reaching US$ million by the year 2028. As for the Europe Amiodarone landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Amiodarone players cover Sanofi, Sawai Pharmaceutical, Wyeth Pharmaceuticals(Pfizer), and Mylan Pharmaceuticals, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Amiodarone market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Tablet Amiodarone

Capsule Amiodarone

Injection Amiodarone

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Cardiac Arrest

Ventricular Tachycardia

Atrial Fibrillation

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Sanofi

Sawai Pharmaceutical

Wyeth Pharmaceuticals(Pfizer)

Mylan Pharmaceuticals

Arrow Pharma Pty Ltd

Roemmers

Cipla Pharmaceutical

Shanghai Pharmaceuticals

North China Pharmaceutical Company

Harbin Pharmaceutical Group

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Amiodarone Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Amiodarone by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Amiodarone by Country/Region, 2017, 2022 & 2028

2.2 Amiodarone Segment by Type

2.2.1 Tablet Amiodarone

2.2.2 Capsule Amiodarone

2.2.3 Injection Amiodarone

2.3 Amiodarone Sales by Type

2.3.1 Global Amiodarone Sales Market Share by Type (2017-2022)

2.3.2 Global Amiodarone Revenue and Market Share by Type (2017-2022)

2.3.3 Global Amiodarone Sale Price by Type (2017-2022)

2.4 Amiodarone Segment by Application

2.4.1 Cardiac Arrest

2.4.2 Ventricular Tachycardia

2.4.3 Atrial Fibrillation

2.4.4 Others

2.5 Amiodarone Sales by Application

2.5.1 Global Amiodarone Sale Market Share by Application (2017-2022)

2.5.2 Global Amiodarone Revenue and Market Share by Application (2017-2022)

2.5.3 Global Amiodarone Sale Price by Application (2017-2022)

3 Global Amiodarone by Company

3.1 Global Amiodarone Breakdown Data by Company

3.1.1 Global Amiodarone Annual Sales by Company (2020-2022)

3.1.2 Global Amiodarone Sales Market Share by Company (2020-2022)

3.2 Global Amiodarone Annual Revenue by Company (2020-2022)

3.2.1 Global Amiodarone Revenue by Company (2020-2022)

3.2.2 Global Amiodarone Revenue Market Share by Company (2020-2022)

3.3 Global Amiodarone Sale Price by Company

3.4 Key Manufacturers Amiodarone Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Amiodarone Product Location Distribution

3.4.2 Players Amiodarone Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Amiodarone by Geographic Region

4.1 World Historic Amiodarone Market Size by Geographic Region (2017-2022)

4.1.1 Global Amiodarone Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Amiodarone Annual Revenue by Geographic Region

4.2 World Historic Amiodarone Market Size by Country/Region (2017-2022)

4.2.1 Global Amiodarone Annual Sales by Country/Region (2017-2022)

4.2.2 Global Amiodarone Annual Revenue by Country/Region

4.3 Americas Amiodarone Sales Growth

4.4 APAC Amiodarone Sales Growth

4.5 Europe Amiodarone Sales Growth

4.6 Middle East & Africa Amiodarone Sales Growth

5 Americas

5.1 Americas Amiodarone Sales by Country

5.1.1 Americas Amiodarone Sales by Country (2017-2022)

5.1.2 Americas Amiodarone Revenue by Country (2017-2022)

5.2 Americas Amiodarone Sales by Type

5.3 Americas Amiodarone Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Amiodarone Sales by Region

6.1.1 APAC Amiodarone Sales by Region (2017-2022)

6.1.2 APAC Amiodarone Revenue by Region (2017-2022)

6.2 APAC Amiodarone Sales by Type

6.3 APAC Amiodarone Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Amiodarone by Country

7.1.1 Europe Amiodarone Sales by Country (2017-2022)

7.1.2 Europe Amiodarone Revenue by Country (2017-2022)

7.2 Europe Amiodarone Sales by Type

7.3 Europe Amiodarone Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Amiodarone by Country

8.1.1 Middle East & Africa Amiodarone Sales by Country (2017-2022)

8.1.2 Middle East & Africa Amiodarone Revenue by Country (2017-2022)

8.2 Middle East & Africa Amiodarone Sales by Type

8.3 Middle East & Africa Amiodarone Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Amiodarone

10.3 Manufacturing Process Analysis of Amiodarone

10.4 Industry Chain Structure of Amiodarone

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Amiodarone Distributors

11.3 Amiodarone Customer

12 World Forecast Review for Amiodarone by Geographic Region

12.1 Global Amiodarone Market Size Forecast by Region

12.1.1 Global Amiodarone Forecast by Region (2023-2028)

12.1.2 Global Amiodarone Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Amiodarone Forecast by Type

12.7 Global Amiodarone Forecast by Application

13 Key Players Analysis

13.1 Sanofi

13.1.1 Sanofi Company Information

13.1.2 Sanofi Amiodarone Product Offered

13.1.3 Sanofi Amiodarone Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Sanofi Main Business Overview

13.1.5 Sanofi Latest Developments

13.2 Sawai Pharmaceutical

13.2.1 Sawai Pharmaceutical Company Information

13.2.2 Sawai Pharmaceutical Amiodarone Product Offered

13.2.3 Sawai Pharmaceutical Amiodarone Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Sawai Pharmaceutical Main Business Overview

13.2.5 Sawai Pharmaceutical Latest Developments

13.3 Wyeth Pharmaceuticals(Pfizer)

13.3.1 Wyeth Pharmaceuticals(Pfizer) Company Information

13.3.2 Wyeth Pharmaceuticals(Pfizer) Amiodarone Product Offered

13.3.3 Wyeth Pharmaceuticals(Pfizer) Amiodarone Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Wyeth Pharmaceuticals(Pfizer) Main Business Overview

13.3.5 Wyeth Pharmaceuticals(Pfizer) Latest Developments

13.4 Mylan Pharmaceuticals

13.4.1 Mylan Pharmaceuticals Company Information

13.4.2 Mylan Pharmaceuticals Amiodarone Product Offered

13.4.3 Mylan Pharmaceuticals Amiodarone Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Mylan Pharmaceuticals Main Business Overview

13.4.5 Mylan Pharmaceuticals Latest Developments

13.5 Arrow Pharma Pty Ltd

13.5.1 Arrow Pharma Pty Ltd Company Information

13.5.2 Arrow Pharma Pty Ltd Amiodarone Product Offered

13.5.3 Arrow Pharma Pty Ltd Amiodarone Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Arrow Pharma Pty Ltd Main Business Overview

13.5.5 Arrow Pharma Pty Ltd Latest Developments

13.6 Roemmers

13.6.1 Roemmers Company Information

13.6.2 Roemmers Amiodarone Product Offered

13.6.3 Roemmers Amiodarone Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Roemmers Main Business Overview

13.6.5 Roemmers Latest Developments

13.7 Cipla Pharmaceutical

13.7.1 Cipla Pharmaceutical Company Information

13.7.2 Cipla Pharmaceutical Amiodarone Product Offered

13.7.3 Cipla Pharmaceutical Amiodarone Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Cipla Pharmaceutical Main Business Overview

13.7.5 Cipla Pharmaceutical Latest Developments

13.8 Shanghai Pharmaceuticals

13.8.1 Shanghai Pharmaceuticals Company Information

13.8.2 Shanghai Pharmaceuticals Amiodarone Product Offered

13.8.3 Shanghai Pharmaceuticals Amiodarone Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Shanghai Pharmaceuticals Main Business Overview

13.8.5 Shanghai Pharmaceuticals Latest Developments

13.9 North China Pharmaceutical Company

13.9.1 North China Pharmaceutical Company Company Information

13.9.2 North China Pharmaceutical Company Amiodarone Product Offered

13.9.3 North China Pharmaceutical Company Amiodarone Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 North China Pharmaceutical Company Main Business Overview

13.9.5 North China Pharmaceutical Company Latest Developments

13.10 Harbin Pharmaceutical Group

13.10.1 Harbin Pharmaceutical Group Company Information

13.10.2 Harbin Pharmaceutical Group Amiodarone Product Offered

13.10.3 Harbin Pharmaceutical Group Amiodarone Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Harbin Pharmaceutical Group Main Business Overview

13.10.5 Harbin Pharmaceutical Group Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Amiodarone Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Amiodarone Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Tablet Amiodarone

Table 4. Major Players of Capsule Amiodarone

Table 5. Major Players of Injection Amiodarone

Table 6. Global Amiodarone Sales by Type (2017-2022) & (M Doses)

Table 7. Global Amiodarone Sales Market Share by Type (2017-2022)

Table 8. Global Amiodarone Revenue by Type (2017-2022) & ($ million)

Table 9. Global Amiodarone Revenue Market Share by Type (2017-2022)

Table 10. Global Amiodarone Sale Price by Type (2017-2022) & (USD/K Doses)

Table 11. Global Amiodarone Sales by Application (2017-2022) & (M Doses)

Table 12. Global Amiodarone Sales Market Share by Application (2017-2022)

Table 13. Global Amiodarone Revenue by Application (2017-2022)

Table 14. Global Amiodarone Revenue Market Share by Application (2017-2022)

Table 15. Global Amiodarone Sale Price by Application (2017-2022) & (USD/K Doses)

Table 16. Global Amiodarone Sales by Company (2020-2022) & (M Doses)

Table 17. Global Amiodarone Sales Market Share by Company (2020-2022)

Table 18. Global Amiodarone Revenue by Company (2020-2022) ($ Millions)

Table 19. Global Amiodarone Revenue Market Share by Company (2020-2022)

Table 20. Global Amiodarone Sale Price by Company (2020-2022) & (USD/K Doses)

Table 21. Key Manufacturers Amiodarone Producing Area Distribution and Sales Area

Table 22. Players Amiodarone Products Offered

Table 23. Amiodarone Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 24. New Products and Potential Entrants

Table 25. Mergers & Acquisitions, Expansion

Table 26. Global Amiodarone Sales by Geographic Region (2017-2022) & (M Doses)

Table 27. Global Amiodarone Sales Market Share Geographic Region (2017-2022)

Table 28. Global Amiodarone Revenue by Geographic Region (2017-2022) & ($ millions)

Table 29. Global Amiodarone Revenue Market Share by Geographic Region (2017-2022)

Table 30. Global Amiodarone Sales by Country/Region (2017-2022) & (M Doses)

Table 31. Global Amiodarone Sales Market Share by Country/Region (2017-2022)

Table 32. Global Amiodarone Revenue by Country/Region (2017-2022) & ($ millions)

Table 33. Global Amiodarone Revenue Market Share by Country/Region (2017-2022)

Table 34. Americas Amiodarone Sales by Country (2017-2022) & (M Doses)

Table 35. Americas Amiodarone Sales Market Share by Country (2017-2022)

Table 36. Americas Amiodarone Revenue by Country (2017-2022) & ($ Millions)

Table 37. Americas Amiodarone Revenue Market Share by Country (2017-2022)

Table 38. Americas Amiodarone Sales by Type (2017-2022) & (M Doses)

Table 39. Americas Amiodarone Sales Market Share by Type (2017-2022)

Table 40. Americas Amiodarone Sales by Application (2017-2022) & (M Doses)

Table 41. Americas Amiodarone Sales Market Share by Application (2017-2022)

Table 42. APAC Amiodarone Sales by Region (2017-2022) & (M Doses)

Table 43. APAC Amiodarone Sales Market Share by Region (2017-2022)

Table 44. APAC Amiodarone Revenue by Region (2017-2022) & ($ Millions)

Table 45. APAC Amiodarone Revenue Market Share by Region (2017-2022)

Table 46. APAC Amiodarone Sales by Type (2017-2022) & (M Doses)

Table 47. APAC Amiodarone Sales Market Share by Type (2017-2022)

Table 48. APAC Amiodarone Sales by Application (2017-2022) & (M Doses)

Table 49. APAC Amiodarone Sales Market Share by Application (2017-2022)

Table 50. Europe Amiodarone Sales by Country (2017-2022) & (M Doses)

Table 51. Europe Amiodarone Sales Market Share by Country (2017-2022)

Table 52. Europe Amiodarone Revenue by Country (2017-2022) & ($ Millions)

Table 53. Europe Amiodarone Revenue Market Share by Country (2017-2022)

Table 54. Europe Amiodarone Sales by Type (2017-2022) & (M Doses)

Table 55. Europe Amiodarone Sales Market Share by Type (2017-2022)

Table 56. Europe Amiodarone Sales by Application (2017-2022) & (M Doses)

Table 57. Europe Amiodarone Sales Market Share by Application (2017-2022)

Table 58. Middle East & Africa Amiodarone Sales by Country (2017-2022) & (M Doses)

Table 59. Middle East & Africa Amiodarone Sales Market Share by Country (2017-2022)

Table 60. Middle East & Africa Amiodarone Revenue by Country (2017-2022) & ($ Millions)

Table 61. Middle East & Africa Amiodarone Revenue Market Share by Country (2017-2022)

Table 62. Middle East & Africa Amiodarone Sales by Type (2017-2022) & (M Doses)

Table 63. Middle East & Africa Amiodarone Sales Market Share by Type (2017-2022)

Table 64. Middle East & Africa Amiodarone Sales by Application (2017-2022) & (M Doses)

Table 65. Middle East & Africa Amiodarone Sales Market Share by Application (2017-2022)

Table 66. Key Market Drivers & Growth Opportunities of Amiodarone

Table 67. Key Market Challenges & Risks of Amiodarone

Table 68. Key Industry Trends of Amiodarone

Table 69. Amiodarone Raw Material

Table 70. Key Suppliers of Raw Materials

Table 71. Amiodarone Distributors List

Table 72. Amiodarone Customer List

Table 73. Global Amiodarone Sales Forecast by Region (2023-2028) & (M Doses)

Table 74. Global Amiodarone Sales Market Forecast by Region

Table 75. Global Amiodarone Revenue Forecast by Region (2023-2028) & ($ millions)

Table 76. Global Amiodarone Revenue Market Share Forecast by Region (2023-2028)

Table 77. Americas Amiodarone Sales Forecast by Country (2023-2028) & (M Doses)

Table 78. Americas Amiodarone Revenue Forecast by Country (2023-2028) & ($ millions)

Table 79. APAC Amiodarone Sales Forecast by Region (2023-2028) & (M Doses)

Table 80. APAC Amiodarone Revenue Forecast by Region (2023-2028) & ($ millions)

Table 81. Europe Amiodarone Sales Forecast by Country (2023-2028) & (M Doses)

Table 82. Europe Amiodarone Revenue Forecast by Country (2023-2028) & ($ millions)

Table 83. Middle East & Africa Amiodarone Sales Forecast by Country (2023-2028) & (M Doses)

Table 84. Middle East & Africa Amiodarone Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Global Amiodarone Sales Forecast by Type (2023-2028) & (M Doses)

Table 86. Global Amiodarone Sales Market Share Forecast by Type (2023-2028)

Table 87. Global Amiodarone Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 88. Global Amiodarone Revenue Market Share Forecast by Type (2023-2028)

Table 89. Global Amiodarone Sales Forecast by Application (2023-2028) & (M Doses)

Table 90. Global Amiodarone Sales Market Share Forecast by Application (2023-2028)

Table 91. Global Amiodarone Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 92. Global Amiodarone Revenue Market Share Forecast by Application (2023-2028)

Table 93. Sanofi Basic Information, Amiodarone Manufacturing Base, Sales Area and Its Competitors

Table 94. Sanofi Amiodarone Product Offered

Table 95. Sanofi Amiodarone Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2022)

Table 96. Sanofi Main Business

Table 97. Sanofi Latest Developments

Table 98. Sawai Pharmaceutical Basic Information, Amiodarone Manufacturing Base, Sales Area and Its Competitors

Table 99. Sawai Pharmaceutical Amiodarone Product Offered

Table 100. Sawai Pharmaceutical Amiodarone Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2022)

Table 101. Sawai Pharmaceutical Main Business

Table 102. Sawai Pharmaceutical Latest Developments

Table 103. Wyeth Pharmaceuticals(Pfizer) Basic Information, Amiodarone Manufacturing Base, Sales Area and Its Competitors

Table 104. Wyeth Pharmaceuticals(Pfizer) Amiodarone Product Offered

Table 105. Wyeth Pharmaceuticals(Pfizer) Amiodarone Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2022)

Table 106. Wyeth Pharmaceuticals(Pfizer) Main Business

Table 107. Wyeth Pharmaceuticals(Pfizer) Latest Developments

Table 108. Mylan Pharmaceuticals Basic Information, Amiodarone Manufacturing Base, Sales Area and Its Competitors

Table 109. Mylan Pharmaceuticals Amiodarone Product Offered

Table 110. Mylan Pharmaceuticals Amiodarone Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2022)

Table 111. Mylan Pharmaceuticals Main Business

Table 112. Mylan Pharmaceuticals Latest Developments

Table 113. Arrow Pharma Pty Ltd Basic Information, Amiodarone Manufacturing Base, Sales Area and Its Competitors

Table 114. Arrow Pharma Pty Ltd Amiodarone Product Offered

Table 115. Arrow Pharma Pty Ltd Amiodarone Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2022)

Table 116. Arrow Pharma Pty Ltd Main Business

Table 117. Arrow Pharma Pty Ltd Latest Developments

Table 118. Roemmers Basic Information, Amiodarone Manufacturing Base, Sales Area and Its Competitors

Table 119. Roemmers Amiodarone Product Offered

Table 120. Roemmers Amiodarone Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2022)

Table 121. Roemmers Main Business

Table 122. Roemmers Latest Developments

Table 123. Cipla Pharmaceutical Basic Information, Amiodarone Manufacturing Base, Sales Area and Its Competitors

Table 124. Cipla Pharmaceutical Amiodarone Product Offered

Table 125. Cipla Pharmaceutical Amiodarone Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2022)

Table 126. Cipla Pharmaceutical Main Business

Table 127. Cipla Pharmaceutical Latest Developments

Table 128. Shanghai Pharmaceuticals Basic Information, Amiodarone Manufacturing Base, Sales Area and Its Competitors

Table 129. Shanghai Pharmaceuticals Amiodarone Product Offered

Table 130. Shanghai Pharmaceuticals Amiodarone Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2022)

Table 131. Shanghai Pharmaceuticals Main Business

Table 132. Shanghai Pharmaceuticals Latest Developments

Table 133. North China Pharmaceutical Company Basic Information, Amiodarone Manufacturing Base, Sales Area and Its Competitors

Table 134. North China Pharmaceutical Company Amiodarone Product Offered

Table 135. North China Pharmaceutical Company Amiodarone Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2022)

Table 136. North China Pharmaceutical Company Main Business

Table 137. North China Pharmaceutical Company Latest Developments

Table 138. Harbin Pharmaceutical Group Basic Information, Amiodarone Manufacturing Base, Sales Area and Its Competitors

Table 139. Harbin Pharmaceutical Group Amiodarone Product Offered

Table 140. Harbin Pharmaceutical Group Amiodarone Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2022)

Table 141. Harbin Pharmaceutical Group Main Business

Table 142. Harbin Pharmaceutical Group Latest Developments

List of Figures

Figure 1. Picture of Amiodarone

Figure 2. Amiodarone Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Amiodarone Sales Growth Rate 2017-2028 (M Doses)

Figure 7. Global Amiodarone Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Amiodarone Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Tablet Amiodarone

Figure 10. Product Picture of Capsule Amiodarone

Figure 11. Product Picture of Injection Amiodarone

Figure 12. Global Amiodarone Sales Market Share by Type in 2021

Figure 13. Global Amiodarone Revenue Market Share by Type (2017-2022)

Figure 14. Amiodarone Consumed in Cardiac Arrest

Figure 15. Global Amiodarone Market: Cardiac Arrest (2017-2022) & (M Doses)

Figure 16. Amiodarone Consumed in Ventricular Tachycardia

Figure 17. Global Amiodarone Market: Ventricular Tachycardia (2017-2022) & (M Doses)

Figure 18. Amiodarone Consumed in Atrial Fibrillation

Figure 19. Global Amiodarone Market: Atrial Fibrillation (2017-2022) & (M Doses)

Figure 20. Amiodarone Consumed in Others

Figure 21. Global Amiodarone Market: Others (2017-2022) & (M Doses)

Figure 22. Global Amiodarone Sales Market Share by Application (2017-2022)

Figure 23. Global Amiodarone Revenue Market Share by Application in 2021

Figure 24. Amiodarone Revenue Market by Company in 2021 ($ Million)

Figure 25. Global Amiodarone Revenue Market Share by Company in 2021

Figure 26. Global Amiodarone Sales Market Share by Geographic Region (2017-2022)

Figure 27. Global Amiodarone Revenue Market Share by Geographic Region in 2021

Figure 28. Global Amiodarone Sales Market Share by Region (2017-2022)

Figure 29. Global Amiodarone Revenue Market Share by Country/Region in 2021

Figure 30. Americas Amiodarone Sales 2017-2022 (M Doses)

Figure 31. Americas Amiodarone Revenue 2017-2022 ($ Millions)

Figure 32. APAC Amiodarone Sales 2017-2022 (M Doses)

Figure 33. APAC Amiodarone Revenue 2017-2022 ($ Millions)

Figure 34. Europe Amiodarone Sales 2017-2022 (M Doses)

Figure 35. Europe Amiodarone Revenue 2017-2022 ($ Millions)

Figure 36. Middle East & Africa Amiodarone Sales 2017-2022 (M Doses)

Figure 37. Middle East & Africa Amiodarone Revenue 2017-2022 ($ Millions)

Figure 38. Americas Amiodarone Sales Market Share by Country in 2021

Figure 39. Americas Amiodarone Revenue Market Share by Country in 2021

Figure 40. United States Amiodarone Revenue Growth 2017-2022 ($ Millions)

Figure 41. Canada Amiodarone Revenue Growth 2017-2022 ($ Millions)

Figure 42. Mexico Amiodarone Revenue Growth 2017-2022 ($ Millions)

Figure 43. Brazil Amiodarone Revenue Growth 2017-2022 ($ Millions)

Figure 44. APAC Amiodarone Sales Market Share by Region in 2021

Figure 45. APAC Amiodarone Revenue Market Share by Regions in 2021

Figure 46. China Amiodarone Revenue Growth 2017-2022 ($ Millions)

Figure 47. Japan Amiodarone Revenue Growth 2017-2022 ($ Millions)

Figure 48. South Korea Amiodarone Revenue Growth 2017-2022 ($ Millions)

Figure 49. Southeast Asia Amiodarone Revenue Growth 2017-2022 ($ Millions)

Figure 50. India Amiodarone Revenue Growth 2017-2022 ($ Millions)

Figure 51. Australia Amiodarone Revenue Growth 2017-2022 ($ Millions)

Figure 52. Europe Amiodarone Sales Market Share by Country in 2021

Figure 53. Europe Amiodarone Revenue Market Share by Country in 2021

Figure 54. Germany Amiodarone Revenue Growth 2017-2022 ($ Millions)

Figure 55. France Amiodarone Revenue Growth 2017-2022 ($ Millions)

Figure 56. UK Amiodarone Revenue Growth 2017-2022 ($ Millions)

Figure 57. Italy Amiodarone Revenue Growth 2017-2022 ($ Millions)

Figure 58. Russia Amiodarone Revenue Growth 2017-2022 ($ Millions)

Figure 59. Middle East & Africa Amiodarone Sales Market Share by Country in 2021

Figure 60. Middle East & Africa Amiodarone Revenue Market Share by Country in 2021

Figure 61. Egypt Amiodarone Revenue Growth 2017-2022 ($ Millions)

Figure 62. South Africa Amiodarone Revenue Growth 2017-2022 ($ Millions)

Figure 63. Israel Amiodarone Revenue Growth 2017-2022 ($ Millions)

Figure 64. Turkey Amiodarone Revenue Growth 2017-2022 ($ Millions)

Figure 65. GCC Country Amiodarone Revenue Growth 2017-2022 ($ Millions)

Figure 66. Manufacturing Cost Structure Analysis of Amiodarone in 2021

Figure 67. Manufacturing Process Analysis of Amiodarone

Figure 68. Industry Chain Structure of Amiodarone

Figure 69. Channels of Distribution

Figure 70. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390